Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 4.46 Delayed Data As of 4:00pm ET |  -0.26 / -5.51%Today’s Change | 3.16 Today|||52-Week Range 9.06 | -22.30% Year-to-Date |
Latest CBAY News | Press Releases
No recent news for Cymabay Therapeutics Inc.
Today’s Trading
| Previous close | 4.72 |
| Today’s open | 4.66 |
| Day’s range | 4.39 - 4.71 |
| Volume | 35,631 |
| Average volume (3 months) | 946,077 |
| Market cap | $320.8M |
Data as of 4:00pm ET, 06/22/2021
Growth & Valuation
| Earnings growth (last year) | +51.74% |
| Earnings growth (this year) | -50.41% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DITAMCON Distributing C... | -4.89 | -3.28% |
| PRTXProtalex Inc | 0.00 | 0.00% |
| OPMZ1PM Industries Inc | 0.00 | 0.00% |
| AXMPAaron Sparks Industr... | 0.00 | 0.00% |
Data as of 1:18pm ET, 06/22/2021
Financials
| Next reporting date | August 12, 2021 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$51.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
